LONDON, October 17, 2017 /PRNewswire/ --
Revenue Prospects for Chemistry Services, Biology Services, Lead Optimisation, Lead Identification and Screening, Leading National Markets and Companies
(Logo: http://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg )
Drug Discovery Outsourcing - our new study reveals trends, R&D progress, and predicted revenues
Where is the Drug Discovery Outsourcing market heading? If you are involved in this sector you must read this newly updated report. Visiongain's report shows you the potential revenues streams to 2027, assessing data, trends, opportunities and business prospects there.
Discover how to stay ahead
Our 225-page report provides 150 tables, charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Drug Discovery Outsourcing market. See how to exploit the opportunities.
Forecasts to 2027 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2027, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.
Discover sales predictions for the world market and submarkets
Along with revenue prediction for the overall world market, there forecasts for 4 Drug Discovery Submarkets,
Global Drug Discovery Outsourcing Submarkets
• Chemistry Services
• Biology Services
• Lead Optimisation
• Lead Identification and Screening
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 13 leading national markets:
• The US
• Germany
• The UK
• Italy
• Spain
• France
• Russia
• Japan
• South Korea
• China
• India
• Brazil
• Mexico
The report also includes profiles and for some of the leading companies in the Drug Discovery Outsourcing market, with a focus on this segment of these companies' operations.
There will be growth in both established and in developing countries. Our analyses show that the both developed and developing markets, India, Brazil and Mexico in particular, will continue to achieve high revenue growth to 2027.
Leading companies and the potential for market growth
Overall world revenue for Drug Discovery Outsourcing will surpass $21bn in 2017, our work calculates. We predict strong revenue growth through to 2027.
Our work identifies which organisations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the Drug Discovery Outsourcing Market report helps you
In summary, our 225-page report provides you with the following knowledge:
• Revenue forecasts to 2027 for the Drug Discovery Outsourcing market, with forecasts for 4 submarkets, each forecasted at a global level - discover the industry's prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2027 for 13 key national markets - See forecasts for the Drug Discovery Outsourcing market in the US, Mexico, Brazil, Germany, France, the UK, Italy, Spain, Russia, China, India, Japan, and South Korea
• Discussion of what stimulates and restrains companies and the market
• Prospects for established firms and those seeking to enter the market - including company profiles for 10 of the major companies involved in the Drug Discovery Outsourcing market
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else
With our newly updated report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions.
Visiongain's study is for everybody needing commercial analyses for the Drug Discovery Outsourcing market and leading companies. You will find data, trends and predictions.
Get our report today Drug Discovery Outsourcing Market Forecast 2017-2027: Revenue Prospects for Chemistry Services, Biology Services, Lead Optimisation, Lead Identification and Screening, Leading National Markets and Companies.
To request a report overview of this report please email Sara Peerun at sara.peerun@visiongain.com or call Tel: +44-(0)-20-7336-6100
Or click on https://www.visiongain.com/Report/2021/Drug-Discovery-Outsourcing-Market-Forecast-2017-2027
Companies Mentioned in the Report
AbbVie
Actavis
Acurian
Advion Bioanalytical Labs
Albany Molecular Research (AMRI)
Apredica
Aptuit
Argenta
Ark Therapeutics
Astex
AstraZeneca
Auspherix
Bayer
Behrman Capital
BGI (Beijing Genomics Institute)
BioCity
Bio Pontis Alliance
BioDuro
BioFocus
Boehringer Ingelheim
Bristol Myers Squibb
Cantab
Caprion Proteomics
Carlyle Group
Catalent
ChanTest
Charles River Laboratories
CHDI
CHDI Foundation
CONBA
Covance
Cyprotex
Domainex
Elan
Eli Lilly
Evotec
Exquiron Biotech
Forma Therapeutics
Galapagos
Genentech
GenScript
GlaxoSmithKline
Great Lakes Chemical Corp
Horizon
Hypha Discovery
IMI
Janssen Pharmaceutical
JingXin
Johnson & Johnson
Kellogg Company
Keucept
Knopp Biosciences
Laboratory Corporation of America
Laurus Labs
MedImmune
Merck
Next CODE Health
Parexel
Pharmaceutical Product Development (PPD)
Ono
Proteros Biostructures
Quintile
Roche
Sanofi
Selcia
Shionogi
Siena Biotech
The Babraham Institute
UCB
Viva Biotech
Vivo Path
WIL Research Laboratories
WuXi AppTec
WuXi PharmaTech
To see a report overview please email Sara Peerun on sara.peerun@visiongain.com
Share this article